Related Experiment Video
Updated: Aug 30, 2025

08:32
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
9.7K
Summary
Genomic copy-number variations reveal unique clonal structures within tumors and adjacent benign tissues. This finding highlights distinct genetic landscapes in cancerous versus non-cancerous cells.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Copy-number variation (CNV) is a key driver of genomic instability in cancer.
- Understanding clonal architecture is crucial for diagnosing and treating cancer.
- Distinguishing tumor-specific CNVs from benign tissue variations is diagnostically important.
Purpose of the Study:
- To investigate the genomic copy-number variation patterns in tumors and adjacent benign tissues.
- To identify distinct clonal patterns indicative of cancerous transformation.
- To assess the utility of CNV analysis for differentiating tumor from benign tissue.
Main Methods:
- Whole-genome sequencing was employed to analyze DNA from tumor and benign tissue samples.
- Copy-number variation analysis was performed across the entire genome.
- Bioinformatic tools were used to identify and compare CNV profiles.
Main Results:
- Significant differences in copy-number variation were observed between tumor and benign tissue samples.
- Distinct clonal patterns of CNVs were identified within the tumor genomes.
- Specific CNV signatures were associated with cancerous tissue, differentiating it from benign counterparts.
Conclusions:
- Genomic copy-number variation analysis effectively distinguishes tumor tissue from adjacent benign tissue.
- The identified clonal patterns provide insights into tumor evolution and heterogeneity.
- CNV profiling represents a valuable tool for cancer diagnostics and research.
Related Concept Videos
T Cell Activation and Clonal Selection
3.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
3.4K
Cadherins in Tissue Organization
3.1K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
3.1K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
3.6K
A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
3.6K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K

